Background: During the coronavirus pandemic there was a rapid adoption of telehealth services in psychiatry, which now accounts for 40% of all visits. There is a dearth of information about the relative efficacy of virtual and in-person psychiatric evaluations.
Methods: We examined the rate of medication changes during virtual and in-person visits as a proxy for the equivalence of clinical decision-making.